MoneyWorks4Me

Medicamen Biotech board recommends final dividend

01 Jun 2019 Evaluate

Medicamen Biotech has informed that the Board of Directors of the Company at its meeting held on May 30, 2019, has recommended a final dividend @ 10% on Equity Shares of Rs 10 each i.e. 1 Rs per Equity Share for the Financial Year 2018-19.

The above information is a part of company's filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..